Industry2h ago
Novo Nordisk Partners With AWS For Drug Discovery
Novo Nordisk named Amazon Web Services its preferred cloud provider to accelerate drug discovery. The partnership integrates AI into pharmaceutical research and operational workflows. It aims to reduce the time required to identify viable drug candidates. Practitioners should watch if this infrastructure shift actually shortens clinical trial timelines or remains a standard corporate cloud migration.